1. Pharmacy Benefit Managers Mount Stiff Lobbying Opposition to Federal Drug Price Transparency Rule
A powerful coalition of pharmacy benefit manager (PBM) and health insurance lobbyists is aggressively fighting a new federal proposal designed to force transparency into the opaque world of prescription drug pricing. The pushback signals a high-stakes battle over a rule that aims to reveal the complex rebates and fees ...